| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.849 | 0.002 | 0.849 | Phosphodiesterase 5A inhibitor | 0.783 0.002 CID_154699671 | ||
| 0.828 | 0.002 | 0.828 | Phosphodiesterase V inhibitor | 0.756 0.002 CID_154699671 | ||
| 0.765 | 0.004 | 0.765 | Phosphodiesterase inhibitor | 0.723 0.004 CID_154699671 | ||
| 0.481 | 0.036 | 0.481 | Toll-Like receptor 7 agonist | 0.445 0.045 CID_154699671 | ||
| 0.48 | 0.036 | 0.48 | Toll-Like receptor agonist | 0.443 0.045 CID_154699671 | ||
| 0.379 | 0.026 | 0.379 | Potassium channel blocker | 0.368 0.028 CID_154699671 | ||
| 0.448 | 0.111 | 0.455 | Antiinflammatory | 0.455 0.108 CID_154699671 | CID_154699671 | |
| 0.312 | 0.037 | 0.312 | Cyclic AMP phosphodiesterase inhibitor | 0.152 0.149 CID_154699671 | ||
| 0.276 | 0.006 | 0.276 | Cyclin A2 inhibitor | 0.237 0.008 CID_154699671 | ||
| 0.27 | 0.024 | 0.27 | Cyclin-dependent kinase inhibitor | 0.185 0.042 CID_154699671 | ||
| 0.246 | 0.007 | 0.246 | Cyclin A inhibitor | 0.221 0.008 CID_154699671 | ||
| 0.287 | 0.053 | 0.287 | HERG channel blocker | 0.217 0.081 CID_154699671 | ||
| 0.219 | 0.008 | 0.219 | CDK2/cyclin E2 inhibitor | 0.174 0.013 CID_154699671 | ||
| 0.334 | 0.134 | 0.334 | Cyclophilin D inhibitor | 0.306 0.158 CID_154699671 | ||
| 0.228 | 0.032 | 0.228 | Polo-like kinase-3 inhibitor | 0.209 0.04 CID_154699671 | ||
| 0.205 | 0.009 | 0.205 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.2 0.01 CID_154699671 | ||
| 0.198 | 0.029 | 0.198 | Protein kinase (CK1) delta inhibitor | 0.158 0.048 CID_154699671 | ||
| 0.189 | 0.021 | 0.189 | CDK/cyclin complex inhibitor | 0.144 0.032 CID_154699671 | ||
| 0.23 | 0.077 | 0.23 | Potassium channel (Voltage-sensitive) blocker | 0.176 0.115 CID_154699671 | ||
| 0.157 | 0.015 | 0.157 | Interleukin 2 antagonist | 0.157 0.015 CID_154699671 | ||
| 0.166 | 0.034 | 0.175 | Aurora-A kinase inhibitor | 0.175 0.032 CID_154699671 | CID_154699671 | |
| 0.142 | 0.018 | 0.142 | Inducible nitric-oxide synthase inhibitor | 0.09 0.048 CID_154699671 | ||
| 0.184 | 0.062 | 0.184 | Src kinase inhibitor | 0.159 0.078 CID_154699671 | ||
| 0.15 | 0.04 | 0.15 | Cyclin-dependent kinase 5 inhibitor | 0.114 0.063 CID_154699671 | ||
| 0.164 | 0.057 | 0.164 | Protein kinase (CK1) inhibitor | 0.115 0.096 CID_154699671 | ||
| 0.176 | 0.07 | 0.176 | MAP kinase kinase 5 inhibitor | 0.163 0.106 CID_154699671 | ||
| 0.151 | 0.046 | 0.151 | TRKB antagonist | 0.133 0.059 CID_154699671 | ||
| 0.135 | 0.03 | 0.135 | Nitric-oxide synthase inhibitor | |||
| 0.158 | 0.054 | 0.158 | Cyclin-dependent kinase 7 inhibitor | 0.144 0.064 CID_154699671 | ||
| 0.145 | 0.043 | 0.145 | Cyclin-dependent kinase 1 inhibitor | 0.1 0.066 CID_154699671 | ||
| 0.128 | 0.026 | 0.156 | ErbB-3 antagonist | 0.156 0.017 CID_154699671 | CID_154699671 | |
| 0.114 | 0.014 | 0.114 | Polo-like kinase-2 inhibitor | 0.111 0.016 CID_154699671 | ||
| 0.145 | 0.046 | 0.145 | Glycogen synthase kinase-3 beta inhibitor | 0.11 0.068 CID_154699671 | ||
| 0.158 | 0.06 | 0.158 | Activin receptor-like kinase 2 inhibitor | |||
| 0.114 | 0.019 | 0.114 | Cyclin E inhibitor | 0.074 0.035 CID_154699671 | ||
| 0.102 | 0.008 | 0.102 | Cyclin A1 inhibitor | 0.095 0.009 CID_154699671 | ||
| 0.186 | 0.093 | 0.202 | Antimitotic | 0.202 0.083 CID_154699671 | CID_154699671 | |
| 0.129 | 0.036 | 0.129 | CDK2/cyclin A inhibitor | 0.121 0.041 CID_154699671 | ||
| 0.161 | 0.069 | 0.161 | Cyclin-dependent kinase 8 inhibitor | 0.131 0.102 CID_154699671 | ||
| 0.109 | 0.017 | 0.109 | Cyclin E1 inhibitor | 0.067 0.029 CID_154699671 | ||
| 0.099 | 0.007 | 0.099 | Cyclin D3 inhibitor | 0.075 0.012 CID_154699671 | ||
| 0.129 | 0.041 | 0.129 | Cyclin-dependent kinase 9 inhibitor | 0.108 0.055 CID_154699671 | ||
| 0.136 | 0.052 | 0.136 | Glycogen synthase kinase-3 inhibitor | 0.103 0.076 CID_154699671 | ||
| 0.219 | 0.136 | 0.219 | Nootropic | |||
| 0.106 | 0.024 | 0.106 | Cyclin-dependent kinase 4 inhibitor | 0.065 0.046 CID_154699671 | ||
| 0.127 | 0.048 | 0.127 | Cyclin-dependent kinase 2 inhibitor | 0.107 0.063 CID_154699671 | ||
| 0.088 | 0.014 | 0.088 | Phosphodiesterase II inhibitor | 0.076 0.02 CID_154699671 | ||
| 0.122 | 0.05 | 0.122 | Activin receptor-like kinase 4 inhibitor | |||
| 0.073 | 0.004 | 0.073 | Phosphodiesterase 6C inhibitor | 0.073 0.004 CID_154699671 | ||
| 0.134 | 0.065 | 0.134 | c-Src kinase inhibitor | 0.116 0.078 CID_154699671 | ||
| 0.106 | 0.037 | 0.106 | Phosphodiesterase I inhibitor | 0.083 0.072 CID_154699671 | ||
| 0.131 | 0.068 | 0.131 | CC chemokine 6 receptor antagonist | 0.126 0.086 CID_154699671 | ||
| 0.093 | 0.031 | 0.093 | Tyk2 inhibitor | 0.088 0.033 CID_154699671 | ||
| 0.092 | 0.032 | 0.092 | Syk tyrosine kinase inhibitor | 0.079 0.041 CID_154699671 | ||
| 0.148 | 0.09 | 0.158 | Tyrosine kinase inhibitor | 0.158 0.085 CID_154699671 | CID_154699671 | |
| 0.074 | 0.016 | 0.074 | Phosphodiesterase 2A inhibitor | 0.062 0.023 CID_154699671 | ||
| 0.075 | 0.019 | 0.075 | Phosphodiesterase 1A inhibitor | |||
| 0.087 | 0.034 | 0.087 | CDK1/cyclin B1 inhibitor | 0.074 0.044 CID_154699671 | ||
| 0.067 | 0.017 | 0.067 | Phosphodiesterase 10A inhibitor | 0.065 0.018 CID_154699671 | ||
| 0.067 | 0.017 | 0.067 | Phosphodiesterase X inhibitor | 0.065 0.018 CID_154699671 | ||
| 0.074 | 0.027 | 0.074 | Cyclin-dependent kinase 6 inhibitor | |||
| 0.072 | 0.029 | 0.072 | CDK4/cyclin D1 inhibitor | 0.05 0.049 CID_154699671 | ||
| 0.155 | 0.114 | 0.155 | Death-associated protein kinase 3 inhibitor | |||
| 0.066 | 0.026 | 0.066 | Toll-Like receptor 8 antagonist | |||
| 0.069 | 0.029 | 0.069 | Cyclin H inhibitor | 0.069 0.029 CID_154699671 | ||
| 0.126 | 0.087 | 0.126 | Growth factor antagonist | 0.121 0.091 CID_154699671 | ||
| 0.086 | 0.047 | 0.086 | Phosphodiesterase 3A inhibitor | 0.075 0.063 CID_154699671 | ||
| 0.067 | 0.029 | 0.067 | CDK4/cyclin D inhibitor | 0.055 0.046 CID_154699671 | ||
| 0.052 | 0.014 | 0.052 | Somatostatin 4 agonist | |||
| 0.112 | 0.075 | 0.115 | TRKA antagonist | 0.115 0.072 CID_154699671 | CID_154699671 | |
| 0.12 | 0.085 | 0.12 | Protein-tyrosine kinase Lyn inhibitor | 0.111 0.092 CID_154699671 | ||
| 0.157 | 0.122 | 0.157 | EphB2 antagonist | |||
| 0.099 | 0.066 | 0.099 | Hedgehog signaling inhibitor | 0.098 0.068 CID_154699671 | ||
| 0.119 | 0.088 | 0.119 | Tyrosine-protein kinase receptor antagonist | 0.115 0.092 CID_154699671 | ||
| 0.041 | 0.013 | 0.041 | CDK6/cyclin D3 inhibitor | 0.034 0.023 CID_154699671 | ||
| 0.068 | 0.04 | 0.068 | CDK1/cyclin B inhibitor | 0.055 0.052 CID_154699671 | ||
| 0.034 | 0.009 | 0.034 | Myristoyl transferase inhibitor | |||
| 0.082 | 0.059 | 0.107 | Insulin like growth factor 1 antagonist | 0.107 0.037 CID_154699671 | CID_154699671 | |
| 0.084 | 0.062 | 0.112 | Insulin growth factor antagonist | 0.112 0.039 CID_154699671 | CID_154699671 | |
| 0.079 | 0.058 | 0.079 | Leucine-rich repeat kinase 2 inhibitor | 0.075 0.062 CID_154699671 | ||
| 0.06 | 0.041 | 0.06 | Potassium channel (Ca-activated) blocker | |||
| 0.15 | 0.133 | 0.15 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.048 | 0.031 | 0.048 | CC chemokine 4 receptor antagonist | 0.043 0.04 CID_154699671 | ||
| 0.109 | 0.094 | 0.109 | Lck kinase inhibitor | |||
| 0.047 | 0.036 | 0.047 | Histamine H4 receptor antagonist | |||
| 0.097 | 0.086 | 0.097 | Aurora-B kinase inhibitor | |||
| 0.166 | 0.157 | 0.166 | Cardiotonic | |||
| 0.076 | 0.068 | 0.076 | Phosphodiesterase XI inhibitor | |||
| 0.076 | 0.068 | 0.076 | Phosphodiesterase 11A inhibitor | |||
| 0.102 | 0.095 | 0.102 | RET inhibitor | |||
| 0.022 | 0.016 | 0.022 | Corticotropin releasing factor 1 receptor antagonist | |||
| 0.029 | 0.024 | 0.029 | Phosphodiesterase 6B inhibitor | 0.027 0.026 CID_154699671 | ||
| 0.082 | 0.078 | 0.082 | Protein kinase C mu inhibitor | |||
| 0.041 | 0.037 | 0.041 | Potassium channel small-conductance Ca-activated blocker | |||
| 0.062 | 0.058 | 0.062 | Protein kinase B alpha inhibitor | |||
| 0.054 | 0.052 | 0.054 | Cyclin B1 inhibitor | |||
| 0.063 | 0.063 | 0.076 | Janus tyrosine kinase 2 inhibitor | 0.076 0.05 CID_154699671 | CID_154699671 | |
| 0.022 | 0.021 | 0.022 | Phosphodiesterase 6H inhibitor | |||
| 0.022 | 0.021 | 0.022 | Phosphodiesterase 6G inhibitor | |||
| 0.076 | 0.089 | 0.091 | Bromodomain-containing protein 2 inhibitor | 0.091 0.054 CID_154699671 | CID_154699671 | |
| 0.058 | 0.073 | 0.069 | ErbB-4 antagonist | 0.069 0.061 CID_154699671 | CID_154699671 | |
| 0.025 | 0.048 | 0.032 | Purinergic P2X3 antagonist | 0.032 0.027 CID_154699671 | CID_154699671 | |
| 0.049 | 0.076 | 0.071 | Janus tyrosine kinase 3 inhibitor | 0.071 0.051 CID_154699671 | CID_154699671 | |
| 0.031 | 0.059 | 0.045 | Glutamate (mGluR5) antagonist | 0.045 0.035 CID_154699671 | CID_154699671 | |
| 0.034 | 0.064 | 0.048 | Bromodomain-containing protein 3 inhibitor | 0.048 0.036 CID_154699671 | CID_154699671 | |
| 0.045 | 0.115 | 0.106 | MAP3K7 inhibitor | 0.106 0.019 CID_154699671 | CID_154699671 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |